# The association between Dietary Obesity-Prevention Score (DOS) and type 2 diabetes (T2D): a case-control study

**Authors:** Amr Ali Mohamed Abdelgawwad El-Sehrawy, Saud Salman Alharbi, Marwah Suliman Maashi, Irfan Ahmad, Soumya V. Menon, Vishal Thakur, D. Alex Anand, Samir Sahoo

PMC · DOI: 10.3389/fnut.2025.1594626 · 2025-07-30

## TL;DR

A study in Saudi Arabia found that following a diet score aimed at preventing obesity is linked to a lower risk of developing type 2 diabetes.

## Contribution

This case-control study demonstrates a 42% reduced odds of T2D with higher adherence to the Dietary Obesity-Prevention Score (DOS).

## Key findings

- Participants in the highest DOS tertile had significantly better dietary intakes of fruits, vegetables, and whole grains.
- Higher DOS adherence was associated with a 42% reduction in T2D risk after adjusting for confounders.
- No significant differences in dietary components were observed between T2D cases and controls.

## Abstract

The global prevalence of type 2 diabetes (T2D) continues to rise, with dietary patterns recognized as a major contributing factor in its development. The Dietary Obesity-Prevention Score (DOS) is a validated tool designed to evaluate adherence to dietary behaviors associated with obesity prevention. This case-control study aimed to examine the association between adherence to the DOS and the risk of developing T2D.

Participants were recruited from individuals attending medical clinics affiliated with King Khalid University in Abha, Saudi Arabia. The study included adults aged 18–60 years, comprising 250 newly diagnosed T2D cases (diagnosed within the past 6 months) and 250 healthy controls. Dietary intake was carefully assessed using a validated semi-quantitative food frequency questionnaire (FFQ), which covered a comprehensive list of 152 food items. The DOS is a validated index derived from 14 food groups known to be associated with changes in body weight.

Participants diagnosed with T2D exhibited significantly higher mean body weight (71. vs. 65.3 kg) and BMI (29.4 vs. 26.2 kg/m2) compared to the control group (p < 0.05). Participants in the highest tertile of the DOS exhibited significantly greater intakes of energy, carbohydrates, various micronutrients, fruits, vegetables, whole grains, and legumes, alongside lower consumption of saturated fatty acids, refined grains, and sugar-sweetened beverages (p < 0.05). No statistically significant differences were observed for these dietary components between the case and control groups. Higher adherence to the DOS was linked to a reduced risk of type 2 diabetes. After adjusting for potential confounders-including age, sex, energy intake, education, marital status, waist circumference, Waist-to-height ratio (WHtR), physical activity, and BMI-those in the highest DOS tertile demonstrated a 42% reduction in the odds of developing T2D compared to individuals in the lowest tertile (OR = 0.58; 95% CI: 0.38–0.87; P-trend = 0.038).

Higher adherence to DOS score associated with a lower risk of T2D among Saudi adults. To validate these findings and clarify the underlying causal mechanisms, further longitudinal studies and randomized controlled trials are warranted.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148), T2D (MONDO:0005148)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}
- **Diseases:** chronic kidney/liver disease (MESH:D051436), DOS (MESH:D009765), insulin resistance (MESH:D007333), nephropathy (MESH:D007674), Diabetes (MESH:D003920), cancer (MESH:D009369), dyslipidemia (MESH:D050171), overweight (MESH:D050177), hypertension (MESH:D006973), hyperglycemia (MESH:D006943), inflammatory compounds (MESH:D005597), endocrine disorders (MESH:D004700), chronic (MESH:D002908), cardiovascular disease (MESH:D002318), PCOS (MESH:D011085), retinopathy (MESH:D058437), weight-loss (MESH:D015431), type 1 or gestational diabetes (MESH:D016640), metabolic diseases (MESH:D008659), T2D (MESH:D003924), inflammation (MESH:D007249), neuropathy (MESH:D009422)
- **Chemicals:** vitamin A (MESH:D014801), selenium (MESH:D012643), vanadium (MESH:D014639), DOS (-), magnesium (MESH:D008274), vitamin B1 (MESH:D013831), cholesterol (MESH:D002784), vitamin B12 (MESH:D014805), vitamin B9 (MESH:D005492), vitamin E (MESH:D014810), butyrate (MESH:D002087), berberine (MESH:D001599), zinc (MESH:D015032), vitamin C (MESH:D001205), PUFAs (MESH:D005231), carbohydrate (MESH:D002241), SCFAs (MESH:D005232), glucose (MESH:D005947), sugar (MESH:D000073893), calcium (MESH:D002118), blood glucose (MESH:D001786), fiber (MESH:D004043), vitamin B6 (MESH:D025101), MUFAs (MESH:D005229), chromium (MESH:D002857), vitamin D (MESH:D014807), mineral (MESH:D008903), saturated fats (MESH:D005227), iron (MESH:D007501)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12343260